Additionally, Moody’s downgraded Tower Health’s outstanding ratings to “A3” from “A2.”
The assignment is a result of several factors, including Tower Health’s solid market position, historically healthy operating performance and favorable absolute liquidity metrics. Moody’s also acknowledged the increased risk associated with the health system’s recent purchase of five hospitals, which resulted in the downgrade of Tower Health’s outstanding ratings.
The outlook is revised to negative from stable, reflecting the increased risk of integrating five formerly for-profit hospitals into the nonprofit health network.
More articles on healthcare finance:
Swedish Health’s Cherry Hill campus no longer at risk of losing Medicare funding
Missouri hospital’s Medicare contract no longer at risk
How to prevent patient misidentification under MACRA
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.